No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
19 and older
Sex
Any
Study type
Observational
Participants needed
165 (estimated)
Sponsor
Seoul National University Hospital · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This prospective, multicenter observational cohort study aims to investigate changes in target lesion hemodynamic parameters, diameter stenosis, plaque characteristics of CCTA before and after the DCB procedure and evaluate their association with clinical outcomes.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Patients with Age ≥ 19
* Patients who took CCTA and were found to have coronary artery disease requiring reperfusion
* Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA.
* The target lesion is…
Inclusion Criteria:
* Patients with Age ≥ 19
* Patients who took CCTA and were found to have coronary artery disease requiring reperfusion
* Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA.
* The target lesion is a de novo lesion with a vessel diameter between 2.25mm and 3.00mm
* Patients deemed suitable for coronary intervention using drug-coated balloon by clinical assessment
* Patients who have been adequately informed about this study and have voluntarily provided written consent to participate.
Exclusion Criteria:
* The target lesion is an in-stent restenosis lesion
* Patient requiring emergency salvage stenting in target lesion
* Patients with a stent previously implanted in the same vessel
* Lesions involving chronic total occlusion or prior coronary artery bypass grafting (CABG).
* Patients with eGFR (estimated glomerular filtration rate) \< 45 ml/min/1.73mm2
* Patients with coronary artery calcium score ≥ 1000 as determined by CCTA
* Patients with an expected survival of less than 5 years
* Pregnant or breastfeeding patients
* Patients deemed inappropriate to participate in this study based on the judgment of study investigators
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.